Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis

Clinical trial NCT00514683 · COMPLETED

Trial details

NCT number: NCT00514683
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Fibrosis

Start date: 2007-08-01
Primary completion: 2010-06-01
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.